Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema Cell · 2026-04-01 · 10.1016/j.cell.2026.01.036 | Dermatology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 92% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Methoxyflurane: analgesic benefit and environmental impact The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00309-0 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 27% · 181 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| More equitable preconception health: paternal life course opportunities for better pregnancy, child, and family outcomes The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00148-0 | Public Health, Environmental and Occupational Health Research article | Baseline Candidate · 1 signal point | 3 citations Cohort 81% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| More self-reflection in research can lead to better science Nature · 2026-04-01 · 10.1038/d41586-026-00965-3 | Decision Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 43% · 7 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Nuclear speckles enable processing of RNA from GC-rich isochores Cell · 2026-04-01 · 10.1016/j.cell.2026.01.011 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 9 citations Cohort 91% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Offline: World war—is it too late? The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00701-4 | General Health Professions Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 36% · 18 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Outrage over UN–Nestlé partnership The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00797-x | Social Sciences Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 81% · 36 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Papuan admixture predated the settlement of Palau Cell · 2026-04-01 · 10.1016/j.cell.2026.02.011 | Social Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 36% · 36 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Perioperative immunotherapy for resectable hepatocellular carcinoma The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00141-8 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 27% · 181 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Perioperative immunotherapy for resectable hepatocellular carcinoma – Authors’ reply The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00294-1 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 27% · 181 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Planetary microbiome structure and generalist-driven gene flow across disparate habitats Cell · 2026-04-01 · 10.1016/j.cell.2025.12.051 | Ecology Research article | Baseline Candidate · 1 signal point | 5 citations Cohort 94% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation Cell · 2026-04-01 · 10.1016/j.cell.2026.01.023 | Immunology Research article | Baseline Candidate · 1 signal point | 9 citations Cohort 81% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Refiloe Masekela: building access to care for childhood lung disease The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00713-0 | Health Professions Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 38% · 20 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Returnees' health vulnerabilities after a 3-year conflict in Sudan The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00547-7 | General Health Professions Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 36% · 18 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Rocatinlimab atopic dermatitis in two global phase 3 clinical trials The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00502-7 | Dermatology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 42% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.